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detection using a novel pre- vs. post- operative specimen collection 
strategy coupled with modern proteomic methods. 
Methods: Serum samples were prepared from patients undergoing 
NSCLC resection - collected both before and 3-6 weeks after surgi-
cal intervention. Our prospective specimen collection efforts currently 
consists of ~ 98 NSCLC ‘paired’ (pre- and post operative) specimens; 
with ~ 54 benign ‘paired’ specimens for comparative purposes. A 
Ciphergen® SELDI-TOF mass spectrometer was used to generate 
the serum proteomic proﬁles, with data acquisition optimized for the 
5,000-40,000 m/z (mass) range. Spectral acquisitions were performed 
with albumin/IgG depleted samples that were concentrated via a 
reversed-phase matrix and collected in quadruplicate batches to further 
ensure reproducibility. Recrystallized a-cyanohydroxylcinnamic acid 
was used as the matrix. Spectral quality was assessed using PROcess a 
speciﬁc library within the Bioconductor R-project statistical platform 
(v2.2.0); with data analyses performed using the Signiﬁcance Analy-
sis of Microarray (SAM) algorithms; all in a blinded manner. Raw 
spectra were processed as follows: spectra pair normalization, baseline 
subtraction, and differential peak detection (with calibrated alignment). 
Aligned peaks were sorted into groups, based on tumor pathology and 
pre- vs. post-operative specimen type, and evaluated for relevance us-
ing a Wilcoxon signed-rank test. 
Results: Pre- and post-operative serum from 16 patients with lung SCC 
had their serum proteomes evaluated for signiﬁcant changes in com-
position. These values were then compared with a set of 10 ‘normal’ 
specimens (i.e. patients undergoing surgery for benign gynecologic or 
pulmonary disease). Even with our small sample size of our prelimi-
nary analysis, we identiﬁed 19 distinct serum components that were 
unique to the preoperative SCC patients, with p<0.05 and a 9.77% 
rate of false discovery. Further, we revealed 13 components that were 
signiﬁcantly reduced or absent (q< 0.05) after tumor resection, with a 
false discovery threshold of 11.14%. From this group, species at m/z 
values of 5336.71, 8587.11, 8842.49, and 14,014.7 seem most promis-
ing, based on their high level of signiﬁcance (q < 0.02). 
Conclusions: These results validate the power of our ‘pre- vs. post- op-
erative’ specimen sets for the identiﬁcation of novel serum biomarker 
candidates for lung squamous cell carcinoma. Efforts are currently fo-
cused on increasing our bank of patient specimens, expanding the study 
to patients with other NSCLC histological sub-types, and identifying 
the reported biomarker candidates via tandem mass spectrometry.
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Background: Reactive Oxygen Species (ROS) are byproducts of 
cellular metabolism. Excess production of ROS originating either 
endogenous or exogenous sources is shown to be a major player in the 
pathogenesis of many diseases as non-small cell lung cancer (NSCLC). 
Knowledge of the difference in ROS between adenocarcinoma (AC) 
and squamous cell carcinoma (SCC) is sparse. The aim of this study 
was to assess the interactions between different markers of oxidative 
stress and compare the results between AC and SCC.
Methods: Twenty eight patients underwent surgery due to a lung or 
a pleural disease. Patients were categorized into three groups: control 
group (N=10) including seven with recurrent pneumothorax, two ham-
artoma and one vascular anomaly, AC (N=11), and SCC (N=7) of the 
lung. For patients with malignant disease, analysis included both the 
tumor and a sample from the resected normal lung tissue. Following 
measurements were analyzed collectively from the samples: myeloper-
oxidase (MP) activity by the amount of oxidation of 3,3’, 5,5’-tetra-
methylbenzidine, glutathione content by Saville’s method, the NADPH 
oxidase activity by lucigenin-enhanced chemiluminescent detection, 
and the amount 8-oxo-dG using HPLC. 
Results: Results are presented in Table 1. 
Conclusion: The present study revealed, especially in AC, increased 
gluthione content and NAPDH oxidase activity, and decreased myelo-
peroxidase activity together with decreased levels of 8-oxo-dG. The 
level of oxidative stress and antioxidant defense seems to be different 
between AC and SCC.
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Promoter methylation is an important mechanism for silencing tumor-
suppressor genes in cancer and it is a promising tool for the develop-
ment of molecular biomarkers. The purpose of the present study was 
to investigate whether inactivation of the A Kinase Anchoring Protein 
12 α (AKAP12α) gene is associated with promoter methylation in lung 
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cancer. The mRNA level of AKAP12α gene was examined by reverse 
transcription-polymerase chain reaction (RT-PCR) in ten lung cancer 
cell lines. The mRNA level of AKAP12α gene was reduced in 6 of 10 
(60%) lung cancer cell lines. The AKAP12α expression was restored 
after treatment with the demethylating agent 5-aza-2’-deoxycytidine 
in lung cancer cell lines which have downregulated mRNA level of 
AKAP12α gene. This result was further substantiated by a luciferase 
reporter assay, showing the restoration of promoter activities when 
transfected with unmethylated AKAP12α promoter. The methyla-
tion status of CpG island 1 and 2 existed in the AKAP12α promoter 
was analyzed by performing bisulﬁte-sequencing analysis in ten lung 
cancer cell lines, forty six lung cancer tissues and matched normal 
tissues. Methylation of CpG island 1 in the AKAP12α promoter was 
detected in 30% of the lung cancer cell lines, whereas methylation of 
CpG island 2 in the AKAP12α promoter was observed in the immor-
talized bronchial cell line and in all the lung cancer cell lines. In all 
of the lung tumors, the CpG island 1 in the AKAP12α promoter was 
infrequently methylated. However, CpG island 2 in the AKAP12α 
promoter was highly methylated in lung tumors compared with the sur-
rounding normal tissues, and this was statistically signiﬁcant (p=0.002). 
Also, the analysis in the methylation level of CpG island 2 and the 
patient’s clinicopathological features was showed that the CpG island 2 
methylation of AKAP12α gene in male, non-recurrence subgroup was 
occurred more frequently than other subgroup. In summary, epigenetic 
AKAP12α silencing seems to be a relevant mechanism of inactivat-
ing this AKAP12α gene in lung cancer and the methylation rate of 
AKAP12α promoter is associated with lung cancer.
This study was supported by a grant of the Ministry of Health & Wel-
fare, Republic of Korea: A010250
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Introduction: Researches of cancer have two ways, in vivo and in vitro. 
Most of them are in vitro and their results are promising. However, us-
ing their results to in vivo had been disappointed because tumor contains 
3 dimensional structure, complicated components, and intercellular 
and/or cell/matrix interactions. Multicellular tumor spheroids (MCTS) 
is a kind of new research area of biology but lack of stromal cells and 
tumor associated macrophages. Artiﬁcial organisms, which have similar 
cell components compare with tumor, will be more complicated and 
advanced model than MCTS. We tried making a multicomponent mul-
ticellular tumor spheroids (MMCTS) from 3 kinds of cells from cancer 
cell from cancer cell line, ﬁbroblasts and peripheral blood mononuclear 
cells(PBMC) from human as a models to cancer research.
Method: A549 cell line, ﬁbroblasts cultured from human, and PBMC 
were cultured on rotatory cell culture system (RCCS) singly or com-
bined in DME media. Their formation of spheroids were observed 2 
times a week by inverted microscope and got samples serially for 4 
weeks. Cell components from combined spheroids were stained immu-
nohistochemically by antibody to cytokeratin, ﬁbroblast and CD68. 
Result: Cells, cultured singly, were aggregated and formed clusters 
except PBMC within a few days and formed spheroids between 4 to 
7 days. Fibroblasts were formed earlier than A549. The mixed cluster 
with A549, ﬁbroblast and PBMC were also formed round shape. Immu-
nohistochemical stain showed that cells from MMCTS preserved their 
characteristics for 4 weeks. 
Conclusion: MMCTS will be a new model for tumor research.
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Design: We investigated histopathological differentiation-associated 
proteins (HD proteins) of non-small cell lung cancer (NSCLC) using 2 
dimensional polyacrylamide gel electrophoresis (2DE) and attempted 
to classify NSCLC. We applied Ettan-DIGE system to 2DE analysis 
and investigated HD proteins on a single 2DE gel to compensate for the 
unfavorable reproducibility of 2DE analysis.
Materials and Methods: We collected samples for 2-DE from repre-
sentative histological types of primary lung cancer, such as squamous 
cell carcinoma, adenocarcinoma and small cell carcinoma between 
2003 and 2005. We selected 8 cases of well or moderately differenti-
ated squamous cell carcinoma conﬁrmed postoperativly to posses 
typical histological features of primary lung squamous cell carcinoma. 
The mixture that contained equal amount of these eight samples was 
regarded as a standard sample of lung squamous cell carcinoma (Sq 
standard sample). In the same way we selected 8 cases of well or mod-
erately differentiated adenocarcinoma to prefers a standard sample of 
primary lung adenocarcinoma (Ad standard sample). We also mixed all 
four cases of small cell carcinoma samples which were collected during 
these periods, and preferred a mixture as a standard sample of small 
cell carcinoma (Sm standard sample). Each standard sample of repre-
sentative histopathological types of primary lung cancer was labeled 
with 400 pmol of a ﬂuorescent dye (either Cy2, Cy3 or Cy5) per 50 µg 
protein according to the manufacturer’s protocol (GE Healthcare Bi-
osicences). Furthermore, using mass spectrometry we identiﬁed protein 
molecules that were detected in 2DE analysis, followed by validation 
analysis by immunohistochemistry.
Results: We detected 7 spots associated with squamous cell carci-
noma, 9 spots associated with adenocarcinoma and 13 spots associated 
with neuroendocrine carcinoma (NE-associated spots) on 2DE gel, 
and succeeded in identifying all histopathological associated proteins 
except three NE-associated proteins (Figure 1, Table 2). Of 29 identi-
ﬁed proteins in this investigation 8 were cytokeratin (CK), which were 
CK5, CK6A, CK8, CK6C, CK6D, CK17, CK18 and CK19. CK5, 
CK6A, CK6C, CK6D and CK17 were identiﬁed as a Sq-associated pro-
tein, and also CK8, CK18 and CK19 were identiﬁed as Ad-associated 
protein. The other identiﬁed proteins we recognized contained napsin 
A and annexin A4. We tried to validate the expression of various kinds 
of CK using immunohistochemical analysis. In CK5, CK5/6 and CK17 
the expression levels in squamous cell carcinoma were greater than in 
the other histopathological types. On the other hand, the expression 
levels of CK8 and CK18 in adenocarcinoma were greater than the other 
